FSTL1 and cervical squamous cell carcinoma: In the CESC cohort, CC patients with low FSTL1 mRNA expression tended to have a poor prognosis (FIGO stage: 0, Log2FSTL1 = 9.11 ± 0.46; I/II, Log2FSTL1 = 7.14 ± 0.09; III-IV, Log2FSTL1 = 6.84 ± 0.15), but the difference was not significant (Figure 2A).